SCHEMBL167744

SCHEMBL167744

OCc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10781780 0.97
SCHEMBL841789 0.80
SCHEMBL38662297 0.80
SCHEMBL38662414 0.80
Bromide SCHEMBL3960568 0.78
Hydrochloric Acid SCHEMBL3939821 0.78
SCHEMBL3787961 0.78 FDPS (0.47)
SCHEMBL8671012 0.78 FDPS (0.47)
SCHEMBL735969 0.77
Alcohol SCHEMBL27675013 0.75 FDPS (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1794 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119591586-A PPD ring-opening derivative and preparation method and application thereof 烟台大学 2025-03-11 CN claimed
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN claimed
CN-115551497-A Compounds with immunomodulatory activity and therapeutic uses thereof 普渡研究基金会 2022-12-30 CN claimed
CN-114437161-A Zidovudine spliced 4-aniline quinazoline compound as well as preparation method and application thereof 遵义医药高等专科学校 2022-05-06 CN claimed
CN-114437046-A 5-fluorouracil spliced 4-aniline quinazoline compound and preparation method and application thereof 遵义医药高等专科学校 2022-05-06 CN claimed
CN-113544129-A Tricyclic compound preparation method and application thereof in medicine field 上海华汇拓医药科技有限公司 2021-10-22 CN claimed
EP-3398950-B1 NOVEL KINASE INHIBITOR AGAINST WILD-TYPE EGFR AND MUTATED EGFR PRECEDO PHARMACEUTICALS CO LTD (CN) 2021-08-11 EP claimed
US-10781214-B2 Kinase inhibitor against wild-type and mutant EGFR PRECEDO PHARMACEUTICALS CO., LTD. (CN) 2020-09-22 US claimed
CN-107344940-B BTK inhibitors and uses thereof 广东东阳光药业有限公司 2020-04-21 CN claimed
US-20190010159-A1 NOVEL KINASE INHIBITOR AGAINST WILD-TYPE AND MUTANT EGFR PRECEDO PHARMACEUTICALS CO., LTD (CN) 2019-01-10 US claimed
US-5773625-A Process for the preparation of disubstituted carbonates ABBOTT LABORATORIES (US) 1998-06-30 US claimed
US-5750558-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES (US) 1998-05-12 US claimed
WO-1997041100-A1 IMINOXY DERIVATIVES OF INDOLE AND INDENE COMPOUNDS AS INHIBITORS OF PROSTAGLANDIN BIOSYNTHESIS ABBOTT LABORATORIES (US) 1997-11-06 WO claimed
EP-0715618-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-06-12 EP claimed
WO-1995006030-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-03-02 WO claimed
WO-1994012179-A1 INDOLE CARBOXYLATE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS ABBOTT LABORATORIES (US) 1994-06-09 WO claimed
US-5288743-A Lipoxygenase inhibitors ABBOTT LABORATORIES (US) 1994-02-22 US claimed
US-5244865-A Herbicides BAYER AKTIENGESELLSCHAFT (DE) 1993-09-14 US claimed
EP-0432740-A2 2-Substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, process for their preparation, medicaments containing them and their utilization HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-19 EP claimed
US-4839352-A ANTIBIOTICS MERCK & CO., INC. (US) 1989-06-13 US claimed